Robert G. Schaub

6.7k total citations · 1 hit paper
154 papers, 5.5k citations indexed

About

Robert G. Schaub is a scholar working on Hematology, Immunology and Surgery. According to data from OpenAlex, Robert G. Schaub has authored 154 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Hematology, 49 papers in Immunology and 26 papers in Surgery. Recurrent topics in Robert G. Schaub's work include Platelet Disorders and Treatments (35 papers), Blood Coagulation and Thrombosis Mechanisms (30 papers) and Cell Adhesion Molecules Research (21 papers). Robert G. Schaub is often cited by papers focused on Platelet Disorders and Treatments (35 papers), Blood Coagulation and Thrombosis Mechanisms (30 papers) and Cell Adhesion Molecules Research (21 papers). Robert G. Schaub collaborates with scholars based in United States, Canada and Austria. Robert G. Schaub's co-authors include Samuel J. Goldman, James C. Keith, Joseph P. Sypek, Derek Sieburth, Charles L. Chung, S F Wolf, S. Mayor, Thomas W. Wakefield, Shirley K. Wrobleski and Daniel D. Myers and has published in prestigious journals such as Circulation, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Robert G. Schaub

153 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response.

1993 639 citations Robert G. Schaub et al. profile →

Peers

Countries citing papers authored by Robert G. Schaub

Since Specialization

Citations

This map shows the geographic impact of Robert G. Schaub's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert G. Schaub with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert G. Schaub more than expected).

Fields of papers citing papers by Robert G. Schaub

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert G. Schaub. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert G. Schaub. The network helps show where Robert G. Schaub may publish in the future.

Co-authorship network of co-authors of Robert G. Schaub

This figure shows the co-authorship network connecting the top 25 collaborators of Robert G. Schaub. A scholar is included among the top collaborators of Robert G. Schaub based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert G. Schaub. Robert G. Schaub is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The novel agonistic iNKT-cell antibody NKT14m induces a therapeutic antitumor response against B-cell lymphoma 2018 ·OncoImmunology ·(unknown), (unknown), A Caballero, Robert G. Schaub, Jorge Sierra, Javier Briones	5
2	NNKTT120, an anti-iNKT cell monoclonal antibody, produces rapid and sustained iNKT cell depletion in adults with sickle cell disease 2017 ·PLoS ONE ·Joshua J. Field, Elaine M. Majerus, Kenneth I. Ataga, Elliott Vichinsky, Robert G. Schaub, Robert Mashal, David G. Nathan	27
3	The role of iNKT cells on the phenotypes of allergic airways in a mouse model 2017 ·Pulmonary Pharmacology & Therapeutics ·Lennart K. A. Lundblad, (unknown), Matthew E. Poynter, (unknown), Oliver Dienz, Jonathan E. Boyson, Nirav Daphtary, Minara Aliyeva, Jennifer L. Ather, Felix Scheuplein, Robert G. Schaub	8
4	Inhibition of von Willebrand factor‐mediated platelet activation and thrombosis by the anti‐von Willebrand factor A1‐domain aptamer ARC1779 2009 ·Journal of Thrombosis and Haemostasis ·Daniel Duerschmied, Yahye Merhi, (unknown), Renta Hutabarat, Jean Charles Gilbert, Denisa D. Wagner, Robert G. Schaub, John L. Diener, H. A. Daniel Lagassé	126
5	A Structural Explanation for the Antithrombotic Activity of ARC1172, a DNA Aptamer that Binds von Willebrand Factor Domain A1 2009 ·Structure ·Ren‐Huai Huang, Daved H. Fremont, John L. Diener, Robert G. Schaub, J. Evan Sadler	75
6	The aptamer ARC1779 is a potent and specific inhibitor of von willebrand factor mediatedex vivoplatelet function in acute myocardial infarction 2009 ·Platelets ·Alexander Spiel, Florian Mayr, (unknown), (unknown), Robert G. Schaub, James C. Gilbert, Bernd Jilma	52
7	Decreased venous thrombosis with an oral inhibitor of P selectin 2005 ·Journal of Vascular Surgery ·Daniel D. Myers, John E. Rectenwald, Patricia W. Bedard, Neelu Kaila, Gray D. Shaw, Robert G. Schaub, Diana Farris, Angela E. Hawley, Shirley K. Wrobleski, Peter K. Henke, Thomas W. Wakefield	74
8	Prevention of in-stent restenosis via reduction of thrombo-inflammatory reactions with recombinant P-selectin glycoprotein ligand-1 2004 ·Thrombosis and Haemostasis ·Jean‐François Tanguay, Pierre A. Geoffroy, Martin G. Sirois, Danielle Libersan, Anjali Kumar, Robert G. Schaub, Yahye Merhi	39
9	Carotid atherosclerosis, vascular risk profile and mortality in a population‐based sample of functionally healthy elderly subjects: the Berlin Ageing Study 2000 ·Journal of Internal Medicine ·Thomas Hillen, (unknown), (unknown), Robert G. Schaub, (unknown), Elisabeth Steinhagen‐Thiessen	54
10	Maternal serum levels of macrophage colony-stimulating factor are associated with adverse pregnancy outcome 2000 ·European Journal of Obstetrics & Gynecology and Reproductive Biology ·James C. Keith, Robert Pijnenborg, C. Luyten, Bernard Spitz, Robert G. Schaub, Frans André Van Assche	11
11	Recombinant human bone morphogenetic protein‐2 is superior to demineralized bone matrix in repairing craniotomy defects in rats 1994 ·Journal of Biomedical Materials Research ·Leslie J. Marden, Jeffrey O. Hollinger, Anshumali Chaudhari, (unknown), Robert G. Schaub, Eyal Ron	125
12	Novel agents that promote bone regeneration 1991 ·Current Opinion in Biotechnology ·Robert G. Schaub, John M. Wozney	4
13	1,4-Dihydronaphthoquinones as water-soluble inhibitors of 5-lipoxygenase 1990 ·Prostaglandins Leukotrienes and Essential Fatty Acids ·Robert G. Schaub, Ayako Yamashita, M K Bach, (unknown), (unknown), Nabil B. Ghazal, Carol A. Simmons, Michael D. Burdick, John R. Brashler, (unknown)	2
14	Comparison of lipid accumulation and metabolism in carrageenan-induced granulomas to aorta and blood monocytes of normal and cholesterol-fed rabbits 1989 ·Experimental and Molecular Pathology ·Frank P. Bell, Robert G. Schaub	8
15	Ciprostene, a stable prostacyclin analog, produces peripheral vasodilation, platelet inhibition and increased clot dissolution in the cat 1988 ·Prostaglandins ·Robert G. Schaub	3
16	Human Protein C produces anticoagulation and increased fibrinolytic activity in the cat 1986 ·Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States) ·(unknown), Robert G. Schaub	2
17	Interaction between canine platelets and adult heartworms: Platelet recognition of heartworm surfaces 1986 ·American Journal of Veterinary Research ·Roger M. Clemmons, Ryosuke Yamaguchi, Robert G. Schaub, Jane Fleming, (unknown), T. L. McDonald	5
18	Treatment of canine dirofilariasis: Pulmonary thromboembolism caused by thiacetarsamide—Microscopic changes 1983 ·American Journal of Veterinary Research ·James C. Keith, Clarence A. Rawlings, Robert G. Schaub	3
19	Reduction of ischemic myocardial damage in the dog by lidocaine infusion. 1977 ·PubMed ·Robert G. Schaub, Gwendolyn J. Stewart, (unknown), Rachel A. Ruotolo, (unknown)	39
20	Effects of lidocaine and epinephrine on myocardial preservation following cardiopulmonary bypass in the dog 1977 ·Journal of Thoracic and Cardiovascular Surgery ·Robert G. Schaub, Gerald M. Lemole, (unknown), Pamela Black, Gwendolyn J. Stewart	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact